IQV241220P310000
- 0.00
- 0.000.00%
IQVIA Holdings Newsroom
RBC Capital Reiterates Outperform on IQVIA Hldgs, Maintains $270 Price Target
Jefferies Raises Price Target on IQVIA Holdings to $200 From $195
Evercore Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $235
IQVIA Holdings (IQV) Receives a Buy From Evercore ISI
A Quick Look at Today's Ratings for IQVIA Holdings(IQV.US), With a Forecast Between $212 to $270
Express News | IQVIA Holdings Inc : TD Cowen Cuts Target Price to $250 From $255
IQVIA Holdings (IQV) Receives a Buy From Stifel Nicolaus
Deutsche Bank Adjusts IQVIA Holdings Price Target to $260 From $265, Maintains Buy Rating
IQVIA Holdings Is Maintained at Neutral by Baird
IQVIA Holdings: Moderate Growth Projections and Neutral Rating Amid Market Expectations
IQVIA Holdings (IQV) Gets a Buy From Barclays
Express News | IQVIA Holdings Inc : Baird Cuts Target Price to $212 From $213
Is IQVIA Holdings Inc.'s (NYSE:IQV) ROE Of 20% Impressive?
The WuXi system welcomes a bullish trend! What is the next catalyst?
Many institutions have indicated that this may be a critical juncture for the healthcare sector.
Express News | China Securities Co.,Ltd.: Still bullish on the development potential and growth space of the CXO sector in the long term.
Catalyst Watch: Goldman Sachs Finance Conference; Adobe, CostCo Earnings
Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 45% Undervaluation?
Stifel Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $273
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Novavax (NVAX) and Veeva Systems (VEEV)
"Laggard" Stocks With Expanding FCF Margins and Attractive FCF Yields – Goldman